Structure Therapeutics has published positive clinical trial results of its experimental daily pill for the treatment of obesity. Patients who took this drug for 44 weeks managed to lose about 16% of their body weight compared to the placebo group. These results led to a significant increase in the company's share price, which rose by 54.2%. The drug represents a new option in the treatment of obesity, which is currently a growing health problem. The results of the trial suggest that a daily pill could be an effective treatment approach for patients with obesity. The company continues to further develop and test this drug.